Loading
Latest filing published 22 Apr 2021 for GenMark Diagnostics, Inc., €3.6M.
Not enough history yet: 0 closed purchases, at least 2 are needed.
All filings by James Fox on record concern GenMark Diagnostics, Inc. In total, 9 filings cover trades dated from 26 May 2016 to 22 April 2021.
The open-market record is one-sided, with 1 purchase worth €44k and not one sale. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Outside the open market, there are 6 share grants.
The record was last updated on 22 April 2021 with a transaction (€3.6M) in GenMark Diagnostics, Inc. The last insider purchase was made public on 10 March 2020, 2,418 days ago. Filings reach the SEC (Form 4) feed a median of 4 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
9 of 9 declarations